The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
SARS-CoV-2: virus dynamics and host response
Open accessAbstract
Since December, 2019, coronavirus disease 2019 (COVID-19) has affected more than 100 000 patients globally. COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has a case-fatality rate of 2·3%, with higher rates among elderly patients and patients with comorbidities. Person-to-person transmission is efficient, with multiple clusters reported. Clinically, patients with COVID-19 present with respiratory symptoms, which is very similar to the presentation of other respiratory virus infections. Radiologically, COVID-19 is characterised by multifocal ground-glass opacities, even for patients with mild disease. Knowledge of virus dynamics and host response are essential for formulating strategies for antiviral treatment, vaccination, and epidemiological control of COVID-19. However, a systematic study on these aspects has not been done. In The Lancet Infectious Diseases, Kelvin To and colleagues report the viral load and antibody profiles of a cohort of 23 patients admitted to hospital with COVID-19. In these patients, the viral load peaked during the first week of illness then gradually declined over the second week. Viral load was also shown to correlate with age. Furthermore, both IgG and IgM antibodies started to increase on around day 10 after symptom onset, and most patients had seroconversion within the first 3 weeks. Finally, the IgG and IgM antibody level against the SARS-CoV-2 internal nucleoprotein and the surface spike receptor binding domain correlated with neutralising activity. These findings have several practical implications. First, the high viral load during the early phase of illness suggests that patients could be most infectious during this period, and it might account for the high transmissibility of SARS-CoV-2. Furthermore, the high viral load on presentation suggests that SARS-CoV-2 could be susceptible to emergence of antiviral resistance. Second, age was associated with viral load in this study, which could explain the high degree of severe disease in older patients with SARS-CoV-2. The high viral load in elderly patients is associated not only with low immunity but also with high expression of the ACE2 receptor (the cellentry receptor for SARS-CoV-2) in older adults. The timing of antibody seroconversion is crucial for determining the optimum timepoints for collecting serum specimens for antibody testing for diagnosis. Furthermore, this information is important for immunologists to choose the best timepoints for obtaining peripheral blood B cells for development of therapeutic monoclonal antibodies. The major strength of the study by To and colleagues is the systematic analysis of the serial viral load and antibody profile for up to 4 weeks, which provides insights into viral and host interactions during the acute and convalescent phases. Another notable aspect is that self-collected posterior oro pharyngeal saliva samples were used, instead of nasopharyngeal specimens, for viral load monitoring. Collection of nasopharyngeal specimens is an invasive procedure, and it is uncomfortable for the patient and poses an infection risk to health-care workers. Self-collected saliva is much more acceptable to patients and is safer for health-care workers. This study clearly shows the feasibility of using saliva for viral load monitoring. The information provided by To and colleagues is solid scientific evidence on COVID-19 for clinicians and scientists. Nonetheless, many questions are still outstanding on the viral characteristics and host response during infection. SARS-CoV-2 has been detected in faeces, blood, and urine samples, and it is important to ascertain viral load dynamics in such samples, for prevention and control of the pandemic. Furthermore, the relation between viral load and disease severity needs to be further clarified. Studies with a larger sample size are needed to understand how different factors can affect viral load or antibody response. For example, immunocompromised patients might have higher viral load, prolonged viral shedding, and impaired antibody response. Future studies in the paediatric population are vital, because children seem to have much milder disease than in adults. Finally, a more detailed understanding of the innate and adaptive immune response against SARS-CoV-2 is important for understanding the pathogenesis and for designing vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,944
To, K. K.-W., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C.-Y., Cai, J.-P., Chan, J. M.-C., Chik, T. S.-H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,066
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
Young, B. E., Ong, S. W. X., Kalimuddin, S., Low, J. G., Tan, S. Y., Loh, J., Ng, O.-T., Marimuthu, K., Ang, L. W., Mak, T. M., et al. (2020) · JAMA · doi:10.1001/jama.2020.3204 · Cited by 2,059
Xu, X.-W., Wu, X.-X., Jiang, X.-G., Xu, K.-J., Ying, L.-J., Ma, C.-L., Li, S.-B., Wang, H.-Y., Zhang, S., Gao, H.-N., et al. (2020) · BMJ · doi:10.1136/bmj.m606 · Cited by 2,046
Self-citationTimely development of vaccines against SARS-CoV-2
Lu, S. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1737580 · Cited by 93
Public health might be endangered by possible prolonged discharge of SARS-CoV-2 in stool
He, Y., Wang, Z., Li, F., & Shi, Y. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.031 · Cited by 48
Chen, Y., Shan, K.-J., & Qian, W. (2020) · Preprints.org · doi:10.20944/preprints202002.0258.v2 · Cited by 39
Self-citation
Cited by
Bourgonje, A. R., Abdulle, A. E., Timens, W., Hillebrands, J., Navis, G. J., Gordijn, S. J., Bolling, M. C., Dijkstra, G., Voors, A. A., Osterhaus, A. D., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5471 · Cited by 1,081
New‐onset autoimmune phenomena post‐COVID‐19 vaccination
Chen, Y., Xu, Z., Wang, P., Li, X., Shuai, Z., Ye, D., & Pan, H. (2022) · Immunology · doi:10.1111/imm.13443 · Cited by 502
Self-citationCOVID-19: Drug Targets and Potential Treatments
Gil, C., Ginex, T., Maestro, I., Nozal, V., Barrado-Gil, L., Cuesta-Geijo, M. Á., Urquiza, J., Ramírez, D., Alonso, C., Campillo, N. E., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00606 · Cited by 445
Ndwandwe, D., & Wiysonge, C. S. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.07.003 · Cited by 381
Diagnostic methods and potential portable biosensors for coronavirus disease 2019
Cui, F., & Zhou, H. S. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112349 · Cited by 373
Metadata
- Authors
- Chen, Y., & Li, L.
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 20
- Issue
- 5
- Pages
- 515-516
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W3012882790
- Cited by
- 286
- References
- 9
- FWCI
- 8.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SARS-CoV-2: virus dynamics and host response. https://app.cochat.ai/papers/10.1016/s1473-3099(20)30235-8
- The paper
- Chen, Y., & Li, L. (2020). SARS-CoV-2: virus dynamics and host response. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(20)30235-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.